Research Scientist
Synthetic Chemistry · Nepal · 2022-03-07
Proposed Endeavor
The petitioner proposes to continue research on developing new chemical reactions to shorten synthetic routes and improve molecular complexity. This work aims to reduce the overall cost of developing drug therapies to treat cancer and other diseases by advancing the production of vital new pharmaceuticals.
Framework Evaluation
3 of 3 criteria metThe research advances the development of vital new drugs and reduces the economic burden of cancer.
The petitioner's record of 6 publications, a patent application, and peer review experience demonstrates his authority in the field.
The petitioner's work is of immense value to public health and millions of people worldwide, justifying the waiver.
Why This Petition Was Approved
Evidence
Similar Cases
Scientist
Pharmaceuticals · New Zealand
Scientist
Pharmaceuticals · India
Postdoctoral Researcher
Pharmaceuticals · Bangladesh
Research Assistant
Pharmaceuticals · China
Frequently Asked Questions
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-03-07.
Browse all casesAt a Glance
EB-2 (NIW) Case Data
Scraped Case Data
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist